Position
Renaissance Technologies in Angiodynamics Inc
Back to the book · All holders of ANGO
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $1.2M$11.37 → $13.01
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 843.1K | $10.8M | — | — | — | 0.0% |
| Q1 2026 | 803.3K | $9.13M | $11.37 | −$1.18M | −$511K | 0.0% |
| Q2 2026 | 733.9K | $9.55M | $13.01 | $1.2M | −$789.1K | 0.0% |